Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myxoma virus | 14 | 2023 | 15 | 5.450 |
Why?
|
| Oncolytic Viruses | 6 | 2022 | 17 | 3.770 |
Why?
|
| Oncolytic Virotherapy | 6 | 2022 | 15 | 3.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2022 | 626 | 1.830 |
Why?
|
| Virus Replication | 5 | 2023 | 104 | 1.690 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2021 | 87 | 1.300 |
Why?
|
| Immunologic Factors | 2 | 2021 | 87 | 1.070 |
Why?
|
| Multiple Myeloma | 2 | 2015 | 92 | 0.880 |
Why?
|
| Virus Diseases | 3 | 2013 | 31 | 0.860 |
Why?
|
| Immunotherapy | 4 | 2022 | 215 | 0.830 |
Why?
|
| Eflornithine | 1 | 2021 | 15 | 0.800 |
Why?
|
| Viruses | 2 | 2013 | 14 | 0.790 |
Why?
|
| Melanoma | 2 | 2022 | 335 | 0.780 |
Why?
|
| Poxviridae | 2 | 2020 | 13 | 0.780 |
Why?
|
| Polyamines | 1 | 2021 | 79 | 0.780 |
Why?
|
| Poxviridae Infections | 2 | 2018 | 4 | 0.750 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 268 | 0.730 |
Why?
|
| Melanoma, Experimental | 2 | 2019 | 95 | 0.700 |
Why?
|
| Interferon-beta | 3 | 2009 | 17 | 0.690 |
Why?
|
| Interferons | 2 | 2009 | 36 | 0.660 |
Why?
|
| Immunomodulation | 1 | 2019 | 35 | 0.650 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 30 | 0.650 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 511 | 0.650 |
Why?
|
| Animal Welfare | 1 | 2018 | 11 | 0.640 |
Why?
|
| Antigens, CD | 2 | 2010 | 230 | 0.610 |
Why?
|
| Antiviral Agents | 3 | 2010 | 211 | 0.580 |
Why?
|
| Gene Expression | 2 | 2019 | 770 | 0.560 |
Why?
|
| Membrane Proteins | 4 | 2010 | 617 | 0.540 |
Why?
|
| Graft vs Host Disease | 2 | 2021 | 163 | 0.520 |
Why?
|
| Interferon Type I | 2 | 2013 | 32 | 0.520 |
Why?
|
| Cytokines | 3 | 2021 | 866 | 0.520 |
Why?
|
| Neoplasms | 3 | 2021 | 1664 | 0.510 |
Why?
|
| Immediate-Early Proteins | 2 | 2006 | 63 | 0.510 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 508 | 0.500 |
Why?
|
| Animals | 16 | 2022 | 20880 | 0.500 |
Why?
|
| Mice | 10 | 2022 | 8474 | 0.450 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 4 | 0.450 |
Why?
|
| Interferon-gamma | 2 | 2013 | 241 | 0.430 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 1851 | 0.410 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 84 | 0.390 |
Why?
|
| Humans | 28 | 2023 | 68549 | 0.380 |
Why?
|
| Lysosomes | 1 | 2010 | 136 | 0.350 |
Why?
|
| Drug Synergism | 3 | 2021 | 260 | 0.350 |
Why?
|
| Tropism | 1 | 2009 | 3 | 0.350 |
Why?
|
| Cytostatic Agents | 1 | 2009 | 4 | 0.350 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 245 | 0.350 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 142 | 0.350 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 266 | 0.340 |
Why?
|
| Endosomes | 3 | 2023 | 45 | 0.320 |
Why?
|
| Proteomics | 2 | 2010 | 246 | 0.320 |
Why?
|
| Vaccinia virus | 4 | 2013 | 97 | 0.320 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 370 | 0.310 |
Why?
|
| Fibroblasts | 3 | 2010 | 902 | 0.310 |
Why?
|
| Ubiquitin | 4 | 2005 | 74 | 0.300 |
Why?
|
| Ligases | 2 | 2004 | 6 | 0.290 |
Why?
|
| Fetal Proteins | 1 | 2006 | 4 | 0.290 |
Why?
|
| Qa-SNARE Proteins | 1 | 2006 | 5 | 0.290 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2006 | 14 | 0.290 |
Why?
|
| Herpesviridae Infections | 1 | 2006 | 23 | 0.280 |
Why?
|
| Herpesvirus 8, Human | 1 | 2006 | 24 | 0.280 |
Why?
|
| Viral Proteins | 2 | 2005 | 149 | 0.270 |
Why?
|
| HeLa Cells | 5 | 2010 | 237 | 0.250 |
Why?
|
| Rabbits | 2 | 2018 | 509 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 2791 | 0.250 |
Why?
|
| Interleukin-12 | 2 | 2022 | 75 | 0.250 |
Why?
|
| Down-Regulation | 3 | 2008 | 447 | 0.240 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 24 | 0.230 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2022 | 132 | 0.220 |
Why?
|
| Virulence | 3 | 2021 | 51 | 0.220 |
Why?
|
| Virion | 1 | 2023 | 31 | 0.220 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 213 | 0.220 |
Why?
|
| Potassium | 1 | 2023 | 168 | 0.210 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 122 | 0.210 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 81 | 0.210 |
Why?
|
| Inflammation | 2 | 2022 | 1030 | 0.200 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 104 | 0.200 |
Why?
|
| Mice, SCID | 2 | 2012 | 238 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2673 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2008 | 89 | 0.200 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 22 | 0.200 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 94 | 0.190 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2550 | 0.190 |
Why?
|
| Interleukins | 1 | 2021 | 79 | 0.190 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 267 | 0.190 |
Why?
|
| Sulfotransferases | 1 | 2020 | 7 | 0.180 |
Why?
|
| Intracellular Space | 1 | 2020 | 42 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 329 | 0.170 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 648 | 0.170 |
Why?
|
| Heparin | 1 | 2020 | 205 | 0.170 |
Why?
|
| Immunophenotyping | 1 | 2019 | 110 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 126 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.160 |
Why?
|
| Cell Line | 3 | 2020 | 1752 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 179 | 0.150 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 597 | 0.150 |
Why?
|
| Apoptosis | 2 | 2015 | 1641 | 0.140 |
Why?
|
| Cell Membrane | 2 | 2010 | 524 | 0.140 |
Why?
|
| Female | 5 | 2022 | 38021 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 148 | 0.130 |
Why?
|
| Cell Death | 1 | 2015 | 329 | 0.120 |
Why?
|
| Lymphocytes | 2 | 2012 | 228 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 729 | 0.120 |
Why?
|
| Virus Attachment | 1 | 2013 | 3 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2077 | 0.110 |
Why?
|
| Leukocytes | 1 | 2013 | 99 | 0.110 |
Why?
|
| CD3 Complex | 1 | 2012 | 35 | 0.110 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2012 | 33 | 0.110 |
Why?
|
| Syndecan-1 | 1 | 2012 | 4 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2013 | 156 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 138 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 132 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 75 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2012 | 191 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 145 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 217 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2008 | 69 | 0.100 |
Why?
|
| Tetraspanin 28 | 1 | 2010 | 4 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2012 | 205 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 116 | 0.090 |
Why?
|
| Stem Cells | 1 | 2012 | 248 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2012 | 291 | 0.090 |
Why?
|
| Virus Internalization | 1 | 2010 | 10 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 139 | 0.090 |
Why?
|
| Proteome | 1 | 2010 | 87 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 100 | 0.090 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 206 | 0.080 |
Why?
|
| Yatapoxvirus | 1 | 2008 | 1 | 0.080 |
Why?
|
| Viral Plaque Assay | 1 | 2008 | 12 | 0.080 |
Why?
|
| Golgi Apparatus | 2 | 2006 | 75 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 20 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 20 | 0.080 |
Why?
|
| Kinetics | 1 | 2009 | 1047 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 1082 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2008 | 144 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2005 | 1446 | 0.070 |
Why?
|
| Monocytes | 1 | 2008 | 210 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 230 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2006 | 27 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 682 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 27 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2006 | 30 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 981 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2015 | 2689 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 498 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 284 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1174 | 0.060 |
Why?
|
| Macrophages | 1 | 2008 | 647 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2004 | 234 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2003 | 42 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2022 | 38 | 0.050 |
Why?
|
| Endocytosis | 1 | 2003 | 113 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 114 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 782 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 160 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2021 | 13 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 307 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 91 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 135 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 434 | 0.030 |
Why?
|
| Protein Binding | 2 | 2008 | 1027 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2222 | 0.030 |
Why?
|
| Sarcoma, Myeloid | 1 | 2012 | 11 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2010 | 14 | 0.020 |
Why?
|
| Genistein | 1 | 2010 | 26 | 0.020 |
Why?
|
| DEAD Box Protein 58 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2008 | 38 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 618 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2008 | 23 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2008 | 41 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 72 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 137 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2008 | 85 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 304 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2008 | 237 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 271 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2005 | 17 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2005 | 22 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2005 | 165 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2003 | 114 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 1015 | 0.010 |
Why?
|
| Male | 1 | 2022 | 37283 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 1213 | 0.010 |
Why?
|